Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
Product Unit Size | Cost | Quantity | Stock |
---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
Cas No. | 2170137-61-6 (free base) |
---|---|
Purity | ≥98% |
Formula | C16H25N5 |
Formula Wt. | 287.41 |
IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
Synonym | KB0742, NSC-834161, NSC834161 |
Appearance | Yellow to brown crystal |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Sulfonylurea; ATP-sensitive K+ channel blocker....
Abl inhibitor.
Aldosterone antagonist.
Nucleoside (deoxyguanosine) analog, ganciclovir...
pan-RAF inhibitor
Vitamin A derivative, acetate ester of retinol....
Peptidyl transferase inhibitor, protein transla...
Mast cell destabilizer; potential TRP antagonis...
Lincosamide; ribosomal translocation and protei...
D-amino acid, incorporated into bacterial cell ...
Cysteine derivative, antioxidant, ROS scavenger...
N-acetyl cysteine conjugate of phenethylisothio...
PLK1 inhibitor.
Purine (hypoxanthine) analog; xanthine oxidase ...
Alcoholic β-glucoside found in willow bark, sa...
Nucleoside (deoxyadenosine) analog; DNA chain t...
Phenol found in Zingiber; PPARγ agonist, 5-HT3...
Endogenous opioid peptide; μOR agonist.
Endogenous neuropeptide hormone; somatostatin a...
5-Lipoxygenase inhibitor.